304 CAR T cells produced in vivo to treat cardiac injury.

303 Exome sequencing identifies a genetic variant with protective effects in cardiovascular disease.

302 Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice.

301 APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans.

300 Modulating the voltage sensor of a cardiac potassium channel shows antiarrhythmic effects.

299 SARS-CoV-2 infection of human iPSC–derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19.

298 Blocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trial.

297 Implantation of a perfusable device into the epicardium enables delivery of therapeutic agents and infiltration of reparative cells into the heart, amplifying the therapeutic effects of FGF-23 in a rat model of myocardial infarction.

296 A transcription factor coordinates cardiomyocyte dedifferentiation and proliferation in adult hearts.

295 The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis.

Free Images for Presentation: sunipix SUNIPIX